Results 191 to 200 of about 9,297,829 (351)
EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche+8 more
wiley +1 more source
Why collective behaviours self-organize to criticality: a primer on information-theoretic and thermodynamic utility measures. [PDF]
Chen Q, Prokopenko M.
europepmc +1 more source
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef+10 more
wiley +1 more source
Bayesian hierarchical modeling of mucosal immune responses and growth efficiency in young animals: Demonstrating the superiority of data-dependent empirical priors. [PDF]
Chatterjee D, Ghosh P.
europepmc +1 more source
Factors affecting efficiency in fumigation with hydrocyanic acid
Hugh Knight
openalex +2 more sources
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon+13 more
wiley +1 more source
Design and comparative analysis of laser-based array systems for UAV detection in surveillance zones. [PDF]
Salhi M+4 more
europepmc +1 more source
The Relation of Posture to Human Efficiency and the Influence of Poise upon the Support and Function of the Viscera [PDF]
JOEL E. GOLDTHWAIT
openalex +1 more source
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková+14 more
wiley +1 more source